Forte Biosciences, Inc.
Clinical trials sponsored by Forte Biosciences, Inc., explained in plain language.
-
New hope for celiac sufferers: experimental drug enters testing
Disease control Recruiting nowThis study is testing whether a new drug called FB102 can help adults with celiac disease better tolerate accidental gluten exposure. Participants will take either the drug or a placebo while following their gluten-free diet, then undergo a controlled gluten challenge. The goal i…
Phase: PHASE2 • Sponsor: Forte Biosciences, Inc. • Aim: Disease control
Last updated Apr 02, 2026 02:27 UTC
-
New drug tested for severe, sudden hair loss
Disease control Recruiting nowThis study is testing an investigational drug called FB102 for people with severe to very severe alopecia areata, a condition that causes sudden hair loss. About 32 participants will be randomly assigned to receive either FB102 or a placebo (an inactive substance) to see if the d…
Phase: PHASE1 • Sponsor: Forte Biosciences, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug trial aims to restore skin color in vitiligo patients
Disease control Recruiting nowThis study is testing an investigational drug called FB102 to see if it is safe and can help restore skin color in adults with non-segmental vitiligo. About 64 participants will be randomly assigned to receive either FB102 or a placebo (an inactive substance) for comparison. Rese…
Phase: PHASE1 • Sponsor: Forte Biosciences, Inc. • Aim: Disease control
Last updated Feb 25, 2026 15:07 UTC